GB Patent

GB9820420D0 — Antiviral combinations

Assigned to Glaxo Group Ltd · Expires 1998-11-11 · 28y expired

What this patent protects

Patent listed against Sustiva.

Drugs covered by this patent

Sustiva (EFAVIRENZ) · Bristol-Myers Squibb

Patent Metadata

Patent number: GB9820420D0
Jurisdiction: GB
Classification: —
Expires: 1998-11-11
Drug substance claim: No
Drug product claim: No
Assignee: Glaxo Group Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.